Tirofiban-related AEs reported to FAERS
Teplizumab-related AEs reported to FAERS
Temozolomide-related AEs reported to FAERS
Deucravacitinib-related AEs identified in FAERS
Ramelteon-related AEs reported to FAERS
Ripretinib-related AEs identified in FAERS
Semaglutide-related ADEs identified in FAERS
Ocrelizumab-related AEs identified in FAERS
Ublituximab-related AEs identified in FAERS
Etrasimod-related AEs identified in FAERS